VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2022 | A comparison of bispecific antibodies emerging in multiple myeloma

Monique Minnema, MD, PhD, University Medical Center Utrecht, Utrecht, Netherlands, gives a brief overview of bispecific antibodies emerging for the treatment of multiple myeloma, highlighting the main differences between BCMA-targeting and GPRC5D-targeting agents. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter